16-30 of 53
James Burton, DM, FRCP
Leonie Kraft, MD
Lucio Manenti, MD, PhD
Emilio Sanchez, MD, PhD
Leonie Kraft, MD
Emilio Sanchez, MD, PhD
James Burton, DM, FRCP
Lucio Manenti, MD, PhD
Leonie Kraft, MD
Improving Sleep and Mental Health in Patients with CKD-aP
MinuteCE®Improving Sleep and Mental Health in Patients with CKD-aP
Leonie Kraft, MD
Lucio Manenti, MD, PhD
James Burton, DM, FRCP
Emilio Sanchez, MD, PhD
- advertisement
CKD-aP or Something Else? Decoding the Diagnosis
MinuteCE®CKD-aP or Something Else? Decoding the Diagnosis
James Burton, DM, FRCP
Emilio Sanchez, MD, PhD
Kappa-Opioid Settings: Real-World Evidence Insights
MinuteCE®Kappa-Opioid Settings: Real-World Evidence Insights
Lucio Manenti, MD, PhD
Emilio Sanchez, MD, PhD
James Burton, DM, FRCP
Emilio Sanchez, MD, PhD
Pruritus In PN and AD: Challenge How You Manage Itch
CME/CEPruritus In PN and AD: Challenge How You Manage Itch
Peter A. Lio, MD
Test Your Skills and Learn From Experts on IL-13 Inhibitors in Moderate to Severe Atopic Dermatitis
CME/CETest Your Skills and Learn From Experts on IL-13 Inhibitors in Moderate to Severe Atopic Dermatitis
Andrew F. Alexis, MD, MPH
Daniel C. Butler, MD
Shawn G. Kwatra, MD
Psoriasis and Obesity: Going Pound for Pound on Comprehensive, Patient-Centered Management
CME/CEPsoriasis and Obesity: Going Pound for Pound on Comprehensive, Patient-Centered Management
Jaime Almandoz, MD, MBA, MRCPI, FTOS, DABOM
Daniel C. Butler, MD
Benjamin Ungar, MD
- advertisement
Clinical Implications of Neoadjuvant Therapy Guideline Updates in Resectable Melanoma
MinuteCE®Clinical Implications of Neoadjuvant Therapy Guideline Updates in Resectable Melanoma
John M. Kirkwood, MD
Sapna Patel, MD
Implementing Guideline-Concordant Care for a Patient With Newly Diagnosed Stage III Melanoma
MinuteCE®Implementing Guideline-Concordant Care for a Patient With Newly Diagnosed Stage III Melanoma
Paolo A. Ascierto, MD
Hussein Tawbi, MD, PhD
Efficacy and Safety Outcomes for Adjuvant Immunotherapy Driving Guideline Recommendations for Stage IIB/IIC Melanoma
MinuteCE®Efficacy and Safety Outcomes for Adjuvant Immunotherapy Driving Guideline Recommendations for Stage IIB/IIC Melanoma
Paolo A. Ascierto, MD
